Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats

被引:52
作者
Atlasz, Tamas
Babai, Norbert
Kiss, Peter
Reglodi, Dora
Tamas, Andrea
Szabadfi, Krisztina
Toth, Gabor
Hegyi, Orsolya
Lubics, Andrea
Gabriel, Robert
机构
[1] Univ Pecs, Fac Med, Dept Anat, H-7624 Pecs, Hungary
[2] Univ Pecs, Dept Expt Zool & Neurobiol, Pecs, Hungary
[3] Univ Szeged, Dept Med Chem, Szeged, Hungary
基金
匈牙利科学研究基金会;
关键词
neuropeptide; neuroprotection; photoreceptor; ischemic injury;
D O I
10.1016/j.ygcen.2006.12.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pituitary adenylate cyclase activating popypeptide (PACAP) is a pleiotropic neuropeptide, exerting neurotrophic and neuroprotective effects in numerous models of in vitro and in vivo nervous injuries. The aim of the present study was to investigate whether PACAP is neuroprotective in ischemic retinal damage. Adult male Wistar rats underwent bilateral carotid occlusion and PACAP was administered Unilaterally into the vitreous body immediately following carotid Occlusion. Retinas were analyzed three weeks after the injury. It was found that bilateral carotid Occlusion led to a severe degeneration of all retinal layers. PACAP treatment significantly ameliorated the carotid occlusion-induced retinal damage: the overall thickness of the retina was significantly more than in control carotid occluded animals and the morphological characteristics of the photoreceptors showed nearly normal appearance. The outer plexiform layer remained discernible and the inner and outer nuclear layers were significantly thicker than in control animals. In summary, Our present study provides evidence, for the first time, that PACAP attenuates ischemic retinal degeneration. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 71 条
[11]   Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-κB interaction in activated microglia [J].
Delgado, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 297 (05) :1181-1185
[12]   Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia [J].
Delgado, M ;
Jonakait, GM ;
Ganea, D .
GLIA, 2002, 39 (02) :148-161
[13]   The significance of vasoactive intestinal peptide in immunomodulation [J].
Delgado, M ;
Pozo, D ;
Ganea, D .
PHARMACOLOGICAL REVIEWS, 2004, 56 (02) :249-290
[14]   Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells [J].
Falluel-Morel, A ;
Aubert, N ;
Vaudry, D ;
Basille, M ;
Fontaine, M ;
Fournier, A ;
Vaudry, H ;
Gonzalez, BJ .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (05) :1231-1243
[15]   Post-ischemic administration of diazoxide attenuates long-term microglial activation in the rat brain after permanent carotid artery occlusion [J].
Farkas, E ;
Timmer, NM ;
Domoki, F ;
Mihály, A ;
Luiten, PGM ;
Bari, F .
NEUROSCIENCE LETTERS, 2005, 387 (03) :168-172
[16]   Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism [J].
Figiel, M ;
Engele, J .
JOURNAL OF NEUROSCIENCE, 2000, 20 (10) :3596-3605
[17]   Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2 [J].
Fontaine, V ;
Mohand-Said, S ;
Hanoteau, N ;
Fuchs, L ;
Pfizenmaier, K ;
Eisel, U .
JOURNAL OF NEUROSCIENCE, 2002, 22 (07)
[18]   Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity [J].
Ganea, D ;
Delgado, M .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (03) :229-237
[19]   Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis [J].
Gasz, B ;
Rácz, B ;
Roth, E ;
Borsiczky, B ;
Ferencz, A ;
Tamás, A ;
Cserepes, B ;
Lubics, A ;
Gallyas, F ;
Tóth, G ;
Lengvári, I ;
Reglodi, D .
PEPTIDES, 2006, 27 (01) :87-94
[20]   Target areas innervated by PACAP-immunoreactive retinal ganglion cells [J].
Hannibal, J ;
Fahrenkrug, J .
CELL AND TISSUE RESEARCH, 2004, 316 (01) :99-113